UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000023148
Receipt number R000026662
Scientific Title A phase Ib/II, multicenter study to investigate the safety, efficacy, and proof-of-concept (POC) of nivolumab monotherapy as a sequential therapy following preoperative chemoradiotherapy in patients with locally advanced resectable rectal cancer
Date of disclosure of the study information 2016/09/01
Last modified on 2023/02/07 13:39:23

No. Disposal Last modified on Item of update
1 Insert 2016/07/13 13:15:46
2 Update 2016/07/22 18:25:34 Interventions/Control_1
Interventions/Control_1
3 Update 2016/07/22 18:27:10 Narrative objectives1
Narrative objectives1
4 Update 2016/07/22 18:28:02 Date of disclosure of the study information
5 Update 2016/07/22 19:54:37 Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
6 Update 2016/07/27 15:17:16 Interventions/Control_1
7 Update 2017/01/14 16:32:00 Recruitment status
8 Update 2017/02/02 14:00:09 Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
9 Update 2017/02/02 15:06:53 Division name
Institutions
10 Update 2017/06/26 14:13:20 Recruitment status
11 Update 2017/09/19 14:29:27 Institutions
12 Update 2017/12/05 10:12:41 Acronym
Acronym
13 Update 2017/12/05 10:14:23 Narrative objectives1
Narrative objectives1
Key secondary outcomes
Key secondary outcomes
14 Update 2017/12/05 10:15:33 Key inclusion criteria
Key inclusion criteria
Target sample size
15 Update 2017/12/05 10:57:02 Key exclusion criteria
Key exclusion criteria
16 Update 2018/01/15 08:19:55 Institutions
17 Update 2018/07/17 08:29:32 Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
18 Update 2019/07/16 09:13:11 Date of IRB
Last follow-up date
19 Update 2019/07/16 09:18:18 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address
Address

Last name of contact person

Last name of contact person
Organization
Organization
Zip code
Address
Address
Address
Organization
Organization
Address
Address
Tel
Email
20 Update 2019/07/16 09:25:15 Target sample size
21 Update 2019/07/16 10:40:11 Key inclusion criteria
22 Update 2019/07/16 11:22:17 Key inclusion criteria
23 Update 2019/07/16 15:00:29 Key inclusion criteria
Key inclusion criteria
24 Update 2020/07/16 13:02:48 Institutions
25 Update 2020/07/16 13:56:52 Classification by specialty
Narrative objectives1
Narrative objectives1
26 Update 2020/07/16 14:13:33 Interventions/Control_1
Interventions/Control_1
Key inclusion criteria
Key inclusion criteria
Target sample size
27 Update 2020/07/16 14:17:46 Key inclusion criteria
28 Update 2020/07/17 08:11:49 Narrative objectives1
29 Update 2020/07/17 08:13:01 Interventions/Control_1
30 Update 2020/07/17 08:14:10 Key inclusion criteria
31 Update 2021/07/16 09:23:01 Last follow-up date
32 Update 2022/07/19 10:07:53 Recruitment status
33 Update 2023/02/06 11:57:38 Recruitment status
34 Update 2023/02/07 13:39:23 URL releasing protocol
Number of participants that the trial has enrolled